Payer

Two Medicare Advantage plans received the National Committee for Quality Assurance's five-star rating for 2024. 

The Cigna Group's pharmacy benefit manager, Express Scripts, is suing the Federal Trade Commission and Chair Lina Khan over what it describes as an "unfair, biased, erroneous, and defamatory" report on pharmacy benefit managers released by the agency earlier this…

The National Committee for Quality Assurance has named the best-rated health plans of 2024 based on nearly 50 factors that include patient experience and clinical quality.

Medicare Advantage plans are planning market exits for 2025, and preparing for open enrollment amid a turbulent year. 

Some Medicare Advantage plans say the turbulence facing the industry is not slowing them down. 

UnitedHealth Group's policy platform is focused on expanding value-based care. 

Debates over the Affordable Care Act have evolved in Washington, D.C., moving away from "repeal and replace" toward navigating premium subsidies set to expire at the end of 2025, The Washington Post reported Sept. 12.

Centene's Fidelis Care has reached a $7.6 million settlement agreement with New York Attorney General Letitia James for billing Medicaid for services provided by an individual convicted of a crime.

Seniors are given the opportunity to switch Medicare Advantage plans annually, but some evidence suggests that committing to multi-year contracts could lead to better health outcomes.

Anthem Blue Cross Blue Shield is requesting payments from some providers it alleges falsified patients' medical records when prescribing Ozempic, Bloomberg reported Sept. 12.